)The top 100 stock
market authors
selected for publication
market authors
selected for publication
Tibcomonkey
»
Comments
» Single Comment
| 
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
-
Brett,
Jan 30 09:35 am
|Rating:
0
0
All Comments by Tibcomonkey »Correction and Clarification to Tysabri Post [View article]
Thanks for correcting the Remicade error. I'm curious about something else though. Other responders to your article made it clear that there are has never been a case of PML with Tysabri in a monotherapy setting. This is the only way that Tysabri can be administered. Therefore there are no links as such to PML in the way that Tysabri is currently being administered. The links are to Tysabti/Avonex and to Tysabry/Azathioprine combination usage and we do not know, in these cases even if Tysabri was a causative agent. Why is so difficult for writers, such as yourself to simply write that there has, to date, in over 20,000 patients, never been a case of PML in Tysabri monotherapy. Surely the MS patients currently taking the medication deserve to know this simple fact instead of being scared by partially false and misleading information?